13/11/2019 Ebersberg, Germany
Eurofins Genomics has just launched a next generation sequencing (NGS) service that enables customers to analyse mutations introduced by the CRISPR/Cas9 system. This new service delivers highly reliable results with the most complete coverage, quickly and conveniently.
23/10/2019 Ebersberg, Germany
Eurofins Genomics, the international provider of genomics services, has made a donation to ‘Ärzte ohne Grenzen / Médecins Sans Frontières’, a humanitarian medical organisation that provides medical aid in conflict zones and countries stricken by endemic diseases around the world.
16/10/2019 Ebersberg, Germany
Eurofins Genomics helps uncover a groundbreaking link between ovarian cancer and the microbiome. As part of one of the first reports of its kind, Eurofins Genomics was a research partner in a project funded by EU Horizon 2020 and Eve Appeal. The results of the research showed that in women at risk of developing ovarian cancer, or those who may already have ovarian cancer, had a significantly decreased amount of “good” lactobacilli bacteria present in their microbiome. These results could have a significant impact on how ovarian cancer risk may be reduced in the future.
17/04/2019 Ebersberg, Germany
Investing in customer service: Eurofins Genomics, international provider of genomics services, now offers next generation sequencing (NGS) services on the NovaSeq6000 (Illumina Inc., US). Using Illumina’s latest and most efficient high throughput sequencing platform, Eurofins Genomics sets new benchmarks in both quality and turnaround time. With the addition of the NovaSeq 6000, Eurofins Genomics now offers tailor-made services on a comprehensive set of NGS platforms including the HighSeq 4000, HiSeq 2500, MiSeq, and equal technology from PacBio.
Agilent Technologies Inc. (NYSE: A) and Eurofins Genomics today announced that Agilent plans to offer custom components and an assembled plasmid service for Agilent's SureVector next-generation cloning kits through a collaboration with Eurofins. Agilent will also offer a set of catalog components for its leading-edge SureVector cloning kits, enabling the creation of over 1 million different cloning vectors.
Eurofins Scientific (EUFI.PA), the global leader in bio-analytical testing, and one of the world leaders in genomic services, announces the opening of its new state-of-the-art manufacturing and services facility in Louisville, KY, in the US. The large, 65,800 ft2 (6,113 m2) facility functions as the Group’s central genomics laboratory in North America, focusing on the custom production of DNA and RNA oligonucleotides synthetic gene synthesis, and genomics services including DNA sequencing, synthetic biology, and next generation sequencing (NGS).
Eurofins Scientific (EUFI.PA), one of the world leaders in genomic services, and Weatherbys Ireland DNA Laboratories, one of Europe’s leading animal genomic laboratories, are pleased to announce that they have been jointly selected to test one million samples of beef for the Irish Cattle Breeding Federation (ICBF) over the next two years.
06/10/2015 Aarhus, Denmark
Certification underlines AROS’ strength for NGS services within the regulatory field.
01/10/2015 Ebersberg, Germany
Eurofins Genomics and tilibit nanosystems launch a global distribution agreement.
27/08/2015 Ebersberg, Germany
Next generation sequencing techniques for microbiome profiling of food, pharma and environmental samples dedicated to industrials and academic services.
03/06/2015 Ebersberg, Germany
Eurofins Genomics and the Institute for Bee Research Hohen Neuendorf e.V. join forces, supported by funds of the program “Research for Innovation in Agriculture”.
20/05/2015 Ebersberg, Germany
Custom cGMP services with highly standardised process controls that meet customer requirements.
12/11/2014 Ebersberg, Germany
GLP accreditation offering the highest quality services to all customers.